2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Prevention of Cardiovascular Disease in Type 1 Diabetes
C Manrique-Acevedo, IB Hirsch… - New England Journal of …, 2024 - Mass Medical Soc
Prevention of Cardiovascular Disease in Type 1 Diabetes | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Y Handelsman, JE Anderson, GL Bakris… - Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
Cardio‐renal‐metabolic disease in primary care setting
M Ibrahim, EM Ba‐Essa, J Baker… - Diabetes/metabolism …, 2024 - Wiley Online Library
In the primary care setting providers have more tools available than ever before to impact
positively obesity, diabetes, and their complications, such as renal and cardiac diseases. It is …
positively obesity, diabetes, and their complications, such as renal and cardiac diseases. It is …
Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists
G Cimino, M Vaduganathan, CM Lombardi… - ESC heart …, 2024 - Wiley Online Library
Heart failure with preserved ejection fraction (HFpEF) has a high prevalence, affecting more
than 50% of patients with heart failure. HFpEF is associated with multiple comorbidities, and …
than 50% of patients with heart failure. HFpEF is associated with multiple comorbidities, and …
Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal …
Q Min, Z Wu, J Yao, S Wang, L Duan, S Liu… - Cardiovascular …, 2024 - Springer
The atherogenic index of plasma (AIP) and cardiovascular disease (CVD) in participants
with abnormal glucose metabolism have been linked in previous studies. However, it was …
with abnormal glucose metabolism have been linked in previous studies. However, it was …
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Hypoxia, characterized by reduced oxygen concentration, is a significant stressor that affects
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …
the survival of aerobic species and plays a prominent role in cardiovascular diseases. From …
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
AJ Scheen - Expert Review of Clinical Pharmacology, 2023 - Taylor & Francis
Introduction Atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are two
major complications of type 2 diabetes (T2DM). Cardiovascular protection is a key objective …
major complications of type 2 diabetes (T2DM). Cardiovascular protection is a key objective …
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
K Schütt, M Federici, M Verket, N Marx… - 2024 - academic.oup.com
Patients with type 2 diabetes (T2DM) exhibited an increased risk to develop cardiovascular
disease (CVD) as well as chronic kidney disease (CKD), and the presence of these …
disease (CVD) as well as chronic kidney disease (CKD), and the presence of these …
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD+-SIRT3 pathway
Y Liu, H Qiu, H Xia, Y Feng, J Deng, Y Yuan… - Acta Pharmacologica …, 2024 - nature.com
Diabetic cardiomyopathy (DCM), one of the most serious long-term consequences of
diabetes, is closely associated with oxidative stress, inflammation and apoptosis in the heart …
diabetes, is closely associated with oxidative stress, inflammation and apoptosis in the heart …